4.3 Article

LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma

Journal

ONCOTARGET
Volume 6, Issue 35, Pages 38005-38015

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.5357

Keywords

lncRNA; MALAT1; miR-200s; ZEB2; KIRC

Funding

  1. National Natural Science Foundation of China [31072238, 31172441, 31372562, 81170650, 81402105, 81402098, 81402087]
  2. Chenguang Program of Wuhan Science and Technology Bereau [2015070404010199]
  3. National Major Scientific and Technological Special Project for Significant New Drugs Development [2012ZX09303018]
  4. NCI [R01CA148759]

Ask authors/readers for more resources

Long non-coding RNA (lncRNAs) play a critical role in the development of cancers. LncRNA metastasis-associated lung adenocarcinoma transcript 1(MALAT1) has recently been identified to be involved in tumorigenesis of several cancers such as lung cancer, bladder cancer and so on. Here, we found that MALAT1 exist a higher fold change (Tumor/Normal) in clear cell kidney carcinoma (KIRC) from The Cancer Genome Atlas (TCGA) Data Portal and a negative correlation with miR-200s family. We further demonstrated MALAT1 promote KIRC proliferation and metastasis through sponging miR-200s in vitro and in vivo. In addition, miR-200c can partly reverse the MALAT1's stimulation on proliferation and metastasis in KIRC. In summary we unveil a branch of the MALAT1/miR-200s/ZEB2 pathway that regulates the progression of KIRC. The inhibition of MALAT1 expression may be a promising strategy for KIRC therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available